-
Signature
-
/s/ John S. Hess, Jr. under Power of Attorney
-
Issuer symbol
-
UTHR
-
Transactions as of
-
16 Jan 2026
-
Net transactions value
-
-$23,049
-
Form type
-
4
-
Filing time
-
20 Jan 2026, 16:30:24 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| MALCOLM JAN |
Director |
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING |
/s/ John S. Hess, Jr. under Power of Attorney |
20 Jan 2026 |
0002028640 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
UTHR |
Common Stock |
Sale |
$23,049 |
-50 |
-14% |
$460.98 |
320 |
16 Jan 2026 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: